Year: 2017
Type: editorial
Abstract: cannot believe that it has been more than two de- cades since we first evaluated real-time continuous glucose monitoring (CGM)-(GlucoWatch Ò ) in patients with type 1 diabetes (T1D).The first real-time CGM (GlucoWatch), which uses a reversed iontophoresis to measure interstitial glucose, was approved to be used for 12 h by the Food and Drug Administration (FDA) in 1999. 1,2Since then, several advancements have led to the availability of many CGM systems MiniMed iPro Ò , Enlite 2 Ò , Enlite Enhanced, Enlite 3 ( Medtronic, Northridge, CA), DexCom STS (Short Term Sensor), Dexcom 3, 7, Gen 4 and 5 Ò (Dexcom, San Diego, CA), and Navigator Ò (Abbott Diabetes Care, Alameda, CA). 3,4All of the CGMs were approved as adjunctive and needed 2-4 calibrations a day. 3,4Bailey et al. highlighted the accuracy of CGMs and clinical implications of accuracy in this supplement. 5Most recently, for the first time, Dexcom Gen 5 was approved as nonadjunctive, and CGM data could be used for insulin dosing decisions, although it still needs 2 calibrations a day. 6Large, multicenter, randomized clinical trials that showed the utility of using CGM were detailed by Slattery et al. in this supplement. 7The first major breakaway came with the launch of FreeStyle Libre ProÔ (professional) or personal-a patch glucose sensor, needing no calibration (factory calibrated) that lasts for 14 days. 8,9reeStyle LibreÔ professional or personal, commonly referred to as ''flash glucose monitoring'' system, where the data are available on demand at any time during 14 days and needs no calibration during its use.Only FreeStyle Libre Pro is currently approved by FDA for professional use. 8Wright et al. emphasized the benefits of flash glucose monitoring professional use with real case series in this supplement. 10he flash glucose monitoring has had a significant uptake in European countries wherever it has been made available.In fact, more recently, I had two of my patients who bought their flash glucose monitoring personal in Europe, and they were very ''impressed'' with its accuracy, ease of use, and liked that flash glucose monitoring did not need any calibrations.There are many reasons for early success and rapid uptake of flash glucose monitoring.These include the following:
Authors: Satish K. Garg, Halis Kaan Akturk
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Abbott Diabetes Care
OpenAlex ID: W2617579124
